We continue to closely monitor IV fluid supplies after a US factory was damaged due to recent storms.
The ³Ô¹ÏÍøÕ¾ Response Group met recently and identified likely delays in the import of sodium chloride 0.9% 50mL bags from the United States because of damage from the recent hurricane to production facilities.
AMA President Dr Danielle McMullen represents the AMA on the ³Ô¹ÏÍøÕ¾ Response Group, ensuring that clinician feedback continues to inform decisions being taken.
The recent meeting of the ³Ô¹ÏÍøÕ¾ Response Group agreed that delays were likely in the arrival of imported products, reducing the ability to rebuild local stock.
A meeting communique from 14 October noted that: “Additional local production has commenced and should be able to meet demand. Supply will likely remain constrained until the end of 2024.
Supply of sodium chloride 0.9% 1000mL and Harmann’s solution 1000mL is expected to continue to be constrained until local stock can be rebuilt”.
The communique calls on health providers to continue to aim for a reduction is usage of these product lines through conservation strategies and by using a smaller volume (500mL) where clinically appropriate.
